C66 -Malignant neoplasm of ureter
Specify the patient
Sex Age Region Period Clinical stage TNMAnalysis settings
Analysis settings Change diagnosisExport options
Applied filters (reset filters)
Sex: |
Age: |
Region: |
Period:
C66 – N =1,189
Year | Stage 1 | Stage 2 | Stage 3 | Stage 4 | Not recorded | Total sum |
1995 | 41.2% | 8.8% | 2.9% | 17.6% | 29.4% | 34 |
1996 | 16% | 24% | 8% | 20% | 32% | 25 |
1997 | 30% | 25% | 10% | 7.5% | 27.5% | 40 |
1998 | 18.2% | 36.4% | 9.1% | 3% | 33.3% | 33 |
1999 | 24.4% | 31.7% | 7.3% | 14.6% | 22% | 41 |
2000 | 30.2% | 14% | 9.3% | 9.3% | 37.2% | 43 |
2001 | 25% | 26.8% | 16.1% | 8.9% | 23.2% | 56 |
2002 | 28.9% | 26.7% | 17.8% | 8.9% | 17.8% | 45 |
2003 | 40.7% | 14.8% | 3.7% | 14.8% | 25.9% | 54 |
2004 | 29.4% | 23.5% | 14.7% | 5.9% | 26.5% | 68 |
2005 | 35.1% | 26.3% | 10.5% | 19.3% | 8.8% | 57 |
2006 | 44.8% | 22.4% | 6% | 13.4% | 13.4% | 67 |
2007 | 43.5% | 24.6% | 11.6% | 10.1% | 10.1% | 69 |
2008 | 37.5% | 17.2% | 18.8% | 26.6% | 0% | 64 |
2009 | 45% | 20% | 11.3% | 16.3% | 7.5% | 80 |
2010 | 43.8% | 18.8% | 13.8% | 17.5% | 6.3% | 80 |
2011 | 35.7% | 17.9% | 14.3% | 21.4% | 10.7% | 84 |
2012 | 34.8% | 17.4% | 2.9% | 20.3% | 24.6% | 69 |
2013 | 42% | 17% | 8% | 15.9% | 17% | 88 |
2014 | 44.6% | 23.9% | 14.1% | 13% | 4.3% | 92 |